Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11756171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic and Pharmacological Analyses of Involvement of Src-family, Syk and Btk Tyrosine Kinases in Platelet Shape Change

  2001cited by this paper
• ADP Is the Cognate Ligand for the Orphan G Protein-coupled Receptor SP1999*

  2001cited by this paper
• Identification of the platelet ADP receptor targeted by antithrombotic drugs

  2001cited by this paper
• Evidence for Two Distinct G-protein-coupled ADP Receptors Mediating Platelet Activation

  1999cited by this paper
• P2Y1‐receptors in human platelets which are pharmacologically distinct from P2YADP‐receptors

  1998cited by this paper
• Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation.

  1998cited by this paper
• A Type II Phosphoinositide 3-Kinase Is Stimulated via Activated Integrin in Platelets

  1998cited by this paper
• Molecular Basis for ADP-induced Platelet Activation

  1998cited by this paper
• Molecular Basis for ADP-induced Platelet Activation

  1998cited by this paper
• The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation.

  1998cited by this paper
• A Novel Integrin-activated Pathway Forms PKB/Akt- stimulatory Phosphatidylinositol 3,4-Bisphosphate via Phosphatidylinositol 3-Phosphate in Platelets*

  1998cited by this paper
• Biphasic activation of PKBalpha/Akt in platelets. Evidence for stimulation both by phosphatidylinositol 3,4-bisphosphate, produced via a novel pathway, and by phosphatidylinositol 3,4,5-trisphosphate.

  1998cited by this paper
• Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors.

  1998cited by this paper
• Integrin signaling: the platelet paradigm.

  1998cited by this paper
• P2 receptor subtypes in the cardiovascular system.

  1998cited by this paper
• Role of P2Y1 purinoceptor in ADP‐induced platelet activation

  1998cited by this paper
• Activation of ADP Receptors and Platelet Function

  1997cited by this paper
• Defective platelet activation in G alpha(q)-deficient mice.

  1997cited by this paper
• Agonist-activated alphavbeta3 on platelets and lymphocytes binds to the matrix protein osteopontin.

  1997cited by this paper
• ADP Receptors on Platelets

  1996cited by this paper
• Phosphoinositide 3-kinase gamma and p85/phosphoinositide 3-kinase in platelets. Relative activation by thrombin receptor or beta-phorbol myristate acetate and roles in promoting the ligand-binding function of alphaIIbbeta3 integrin.

  1996cited by this paper
• Identification of competitive antagonists of the P2Y1 receptor.

  1996cited by this paper
• Long Term Aspirin in the Prevention of Cardiovascular Disorders

  1995cited by this paper
• A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis.

  1995cited by this paper
• The human platelet ADP receptor activates Gi2 proteins.

  1995cited by this paper
• Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors.

  1994cited by this paper
• Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor.

  1993cited by this paper
• Thrombin-induced phosphorylation and activation of Ca(2+)-sensitive cytosolic phospholipase A2 in human platelets.

  1993cited by this paper
• Pharmacological receptors on blood platelets.

  1991cited by this paper
• Monoclonal antibodies to ligand-occupied conformers of integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function.

  1991cited by this paper
• Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function.

  1990cited by this paper
• Effect of the Concentration of Ca2+ in the Suspending Medium on the Responses of Human and Rabbit Platelets to Aggregating Agents

  1989cited by this paper
• Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.

  1987cited by this paper
• Inhibitors of Na+/H+ exchange block epinephrine- and ADP-induced stimulation of human platelet phospholipase C by blockade of arachidonic acid release at a prior step.

  1986cited by this paper
• Evidence that Na+/H+ exchange regulates receptor-mediated phospholipase A2 activation in human platelets.

  1986cited by this paper
• Extracellular ATP: effects, sources and fate.

  1986cited by this paper
• Activation of phospholipases A and C in human platelets exposed to epinephrine: role of glycoproteins IIb/IIIa and dual role of epinephrine.

  1986cited by this paper
• Inhibitors of Na+/H+ exchange block stimulus-provoked arachidonic acid release in human platelets. Selective effects on platelet activation by epinephrine, ADP, and lower concentrations of thrombin.

  1985cited by this paper
• The activation by Ca2+ of platelet phospholipase A2. Effects of dibutyryl cyclic adenosine monophosphate and 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate.

  1978cited by this paper
• Prostaglandins and thromboxanes.

  1978cited by this paper
• Interrelations of platelet aggregation and secretion.

  1977cited by this paper

• Preliminary In Vitro Antiplatelet Potential of Ipomoea pes-caprae from North Lombok with Adenosine Diphosphate-Induced Platelet Aggregation

  2025cites this paper
• Effects and molecular mechanisms of farnesyltransferase inhibitor tipifarnib on platelet activation.

  2025cites this paper
• Protective Effects of Nerolidol on Thrombotic Events, Systemic Inflammation, Oxidative Stress, and DNA Damage Following Pulmonary Exposure to Diesel Exhaust Particles

  2025cites this paper
• The role of P2Y1R in cardiovascular diseases and recent development of P2Y1R antagonists.

  2025cites this paper
• Platelet flux in trauma-associated venous thromboembolism: A secondary analysis of the Consortium of Leaders in the Study of Traumatic Thromboembolism (CLOTT) studies

  2025cites this paper
• A comprehensive comparison on hemostatic performance of natural and synthetic nano-clay minerals embedded in modified cellulose-based sponge for non-compressible massive bleedings.

  2025cites this paper
• LRP5, a WNT signalling pathway receptor, and platelet activation.

  2025cites this paper
• Impact of Anemia on Clinical Outcomes in Atrial Fibrillation Patients on Oral Anticoagulants: A Prognostic Meta‐Analysis

  2024cites this paper
• Platelet Spreading and Clot Retraction are Regulated by two Distinct αIIbβ3 Outside-in Signaling Pathways.

  2024cites this paper
• Changes in platelet maturity and reactivity following acute ST-segment elevation myocardial infarction

  2024cites this paper
• Antiplatelet Effect of Daphnetin Is Regulated by cPLA2-Mediated Thromboxane A2 Generation in Mice

  2023cites this paper
• Mitochondrial gene expression is required for platelet function and blood clotting.

  2023cites this paper
• Comprehensive multiparameter evaluation of platelet function using a highly sensitive membrane capacitance sensor.

  2023cites this paper
• Role of Prednisolone in Platelet Activation by Inhibiting TxA2 Generation through the Regulation of cPLA2 Phosphorylation

  2023cites this paper
• PLATELET RESISTANCE TO ANTI-AGGREGATING EFFECT OF CLOPIDOGREL IN SOLID TUMOR PATIENTS

  2022cites this paper
• Purinergic receptors mediate endothelial dysfunction and participate in atherosclerosis

  2022cites this paper
• Evidence for a PI3-kinase independent pathway in the regulation of Rap1b activation downstream of the P2Y12 receptor in platelets

  2022cites this paper
• D121 Located within the DRY Motif of P2Y12 Is Essential for P2Y12-Mediated Platelet Function

  2022cites this paper
• Expression and functional characterization of the large‐conductance calcium and voltage‐activated potassium channel Kca1.1 in megakaryocytes and platelets

  2021cites this paper
• Identification of the functional food ingredients with antithrombotic properties via virtual screen and experimental studies.

  2021cites this paper
• Microstructure Aware Modeling Of Biochemical Transport In Arterial Blood Clots

  2021cites this paper
• Platelet functional responses and signalling: the molecular relationship. Part 2: receptors.

  2021cites this paper
• Inflammatory cell-associated tumors. Not only macrophages (TAMs), fibroblasts (TAFs) and neutrophils (TANs) can infiltrate the tumor microenvironment. The unique role of tumor associated platelets (TAPs)

  2020cites this paper
• First In-Human Experience With Inhaled Acetylsalicylic Acid for Immediate Platelet Inhibition: Comparison With Chewed and Swallowed Acetylsalicylic Acid.

  2020cites this paper
• The molecular basis of platelet biogenesis, activation, aggregation and implications in neurological disorders

  2020cites this paper
• High-molecular-weight fucosylated glycosaminoglycan induces human platelet aggregation depending on αIIbβ3 and platelet secretion

  2020cites this paper
• Purine Metabolism in Platelets and Heart Cells of Hyperlipidemic Rats

  2020cites this paper
• Platelet activation and prothrombotic mediators at the nexus of inflammation and atherosclerosis: Potential role of antiplatelet agents.

  2020cites this paper
• P2Y12 deficiency in mouse impairs noradrenergic system in brain, and alters anxiety‐like neurobehavior and memory

  2019cites this paper
• A highly efficient, in situ wet-adhesive dextran derivative sponge for rapid hemostasis.

  2019cites this paper
• Syntaxin 11 regulates platelet granule release and hemostasis

  2019cites this paper
• Design, synthesis and evaluation of phenylfuroxan nitric oxide-donor phenols as potential anti-diabetic agents.

  2019cites this paper
• The antithrombotic activity of the active fractions from the fruits of Celastrus orbiculatus Thunb through the anti-coagulation, anti-platelet activation and anti-fibrinolysis pathways.

  2019cites this paper
• Role of NF-κB in Platelet Function

  2019cites this paper
• Anti‑platelet activity of mineral‑balanced deep sea water is mediated via the regulation of Akt and ERK pathway crosstalk.

  2019cites this paper
• Cell Type-Specific Mechanisms in the Pathogenesis of Ischemic Stroke: The Role of Apoptosis Signal-Regulating Kinase 1

  2018cites this paper
• Cardiovascular Translational Medicine ( X ) Lipoproteins , Platelets , and Atherothrombosis

  2018cites this paper
• PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway: comment

  2018cites this paper
• Biology of Platelet Purinergic Receptors and Implications for Platelet Heterogeneity

  2018cites this paper
• Platelet procoagulant phenotype is modulated by a p38-MK2 axis that regulates RTN4/Nogo proximal to the endoplasmic reticulum: utility of pathway analysis.

  2018cites this paper
• PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway

  2018cites this paper
• Activation of Hepatic Stellate Cells During Liver Carcinogenesis Requires Fibrinogen/Integrin αvβ5 in Zebrafish

  2018cites this paper
• Role of heterotrimeric G proteins in platelet activation and clot formation in platelets treated with integrin αIIbβ3 inhibitor

  2018cites this paper
• Anti-inflammatory effects of anti-platelet drugs : implications for atherosclerosis

  2018cites this paper
• Inhibitory Effect of Lantana camara L., Eclipta prostrata (L.) L. and Cosmos caudatus Kunth. Leaf Extracts on ADP-Induced Platelet Aggregation

  2018cites this paper
• PLATELET DYSFUNCTION IN PATIENTS WITH MDS AND ITP

  2017cites this paper
• Correlation between individual inflammation genetic profile and platelet rich plasma efficacy in hair follicle regeneration: a pilot study reveals prognostic value of IL-1a polymorphism.

  2017cites this paper
• Knockout of P2Y12 aggravates experimental autoimmune encephalomyelitis in mice via increasing of IL-23 production and Th17 cell differentiation by dendritic cells.

  2017cites this paper
• Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?

  2017influential citation
• Prevention of acute ischemic heart disease by using estrogenic metabolites

  2017cites this paper
• Blood coagulation evaluation of N-alkylated chitosan.

  2017cites this paper
• Hemocompatibility studies on a degradable polar hydrophobic ionic polyurethane (D-PHI).

  2017cites this paper
• The Role of Platelets in Cardiovascular Disease: Molecular Mechanisms.

  2016cites this paper
• Regulation of monocyte anti-thrombotic gene and protein expression through platelet-derived material

  2016cites this paper
• How to test the effect of aspirin and clopidogrel in patients on dual antiplatelet therapy?

  2016cites this paper
• Procoagulant and Anti-Fibrinolytic Properties of Cell-free DNA and Histones in Sepsis

  2016influential citation
• Attenuation of Thrombosis by Crude Rice (Oryza sativa) Bran Policosanol Extract: Ex Vivo Platelet Aggregation and Serum Levels of Arachidonic Acid Metabolites

  2016cites this paper
• Clopidogrel Versus Aspirin as an Antiplatelet Monotherapy After 12-Month Dual-Antiplatelet Therapy in the Era of Drug-Eluting Stents

  2016cites this paper
• Blood cells: an historical account of the roles of purinergic signalling

  2015cites this paper
• dl-3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterase

  2015cites this paper
• Biomarkers Associated with Ischemic Stroke in Diabetes Mellitus Patients

  2015cites this paper
• Platelets in hemostasis and thrombosis: Novel mechanisms of fibrinogen-independent platelet aggregation and fibronectin-mediated protein wave of hemostasis

  2015cites this paper
• Individual Platelet Adhesion (iPA): A novel assay of platelet function

  2014cites this paper
• On-chip evaluation of platelet adhesion and aggregation upon exposure to mesoporous silica nanoparticles.

  2014cites this paper
• DOES THE INHIBITION OF P2Y12 INHIBIT THE PRODUCTION OF THROMBOXANE A2 BY PLATELETS

  2014cites this paper
• Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based model

  2014cites this paper
• High on-treatment platelet reactivity in patients with ischemic cerebrovascular disease: assessment of prevalence and stability over time using four platelet function tests

  2014cites this paper
• Nucleolin Down-Regulation Is Involved in ADP-Induced Cell Cycle Arrest in S Phase and Cell Apoptosis in Vascular Endothelial Cells

  2014cites this paper
• Effect of aspirin intake at bedtime versus on awakening on circadian rhythm of platelet reactivity

  2014cites this paper
• effect of aspirin intake on awakening or at bedtime on circadian rhythm of platelet reactivity in healthy subjects: a randomized cross-over trial

  2014cites this paper
• Harnessing the platelet signaling network to produce an optimal hemostatic response.

  2013cites this paper
• Single Nucleotide Polymorphism Network: A Combinatorial Paradigm for Risk Prediction

  2013cites this paper
• A Boolean view separates platelet activatory and inhibitory signalling as verified by phosphorylation monitoring including threshold behaviour and integrin modulation.

  2013cites this paper
• Platelet microRNAs: From platelet biology to possible disease biomarkers and therapeutic targets

  2013cites this paper
• Platelets and atherothrombosis: causes, targets and treatments for thrombosis.

  2013cites this paper
• Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation.

  2013cites this paper
• MicroRNAs: Novel diagnostic and prognostic biomarkers in atherosclerosis.

  2013cites this paper
• TWO DISTINCT ROLES OF INTEGRIN αIIbβ3 'OUTSIDE-IN' SIGNALING: PLATELET SPREADING AND CLOT RETRACTION

  2012cites this paper
• Novel furfurylidene N-acylhydrazones derived from natural safrole: discovery of LASSBio-1215, a new potent antiplatelet prototype

  2012cites this paper
• Platelet signalling networks: Pathway perturbation demonstrates differential sensitivity of ADP secretion and fibrinogen binding

  2012cites this paper
• Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice.

  2012cites this paper
• Distinct and overlapping functional roles of Src family kinases in mouse platelets

  2012cites this paper
• The effect of the flavonols quercetin and 3', 4' dihydroxyflavonol on platelet function in vitro and in vivo

  2012influential citation
• The platelet fibrinogen receptor: from megakaryocyte to the mortuary

  2012cites this paper
• NPP4 is a procoagulant enzyme on the surface of vascular endothelium.

  2012cites this paper
• The Synthesis and Use of Certain Pyridine Derivatives as Modulators of the G-protein Coupled Receptors mGlu 5 and P 2 Y 12

  2012cites this paper
• Submaximal Inhibition of Protein Kinase C Restores ADP-induced Dense Granule Secretion in Platelets in the Presence of Ca2+*

  2011cites this paper
• Screening active components of herbal drug based on their affinity

  2011cites this paper
• Characterization of the cytokine profile of platelet rich plasma (PRP) and PRP-induced cell proliferation and migration: Upregulation of matrix metalloproteinase-1 and -9 in HaCaT cells

  2011cites this paper
• A new function for the calcineurin b subunit: Antiplatelet aggregation and anticoagulation

  2011cites this paper
• Platelets at work in primary hemostasis.

  2011cites this paper
• Extracellular Ca2+ modulates ADP-evoked aggregation through altered agonist degradation: implications for conditions used to study P2Y receptor activation

  2011cites this paper
• In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation

  2011cites this paper
• Anti-platelet therapy: ADP receptor antagonists

  2011cites this paper
• Aspirin: Pharmacology and Clinical Applications

  2011cites this paper
• G12/13 Signaling Pathways Substitute for Integrin αIIbβ3-Signaling for Thromboxane Generation in Platelets

  2011cites this paper
• The phytotoxin fusicoccin promotes platelet aggregation via 14-3-3-glycoprotein Ib-IX-V interaction.

  2011cites this paper
• Contribution of the P2Y12 receptor‐mediated pathway to platelet hyperreactivity in hypercholesterolemia

  2011cites this paper
• Antagonism of P2Y12 reduces physiological thromboxane levels

  2010cites this paper
• ACETYLSALICYLIC ACID ENHANCES PURINERGIC RECEPTOR‐MEDIATED OUTWARD CURRENTS IN RAT MEGAKARYOCYTES

  2010cites this paper